
Charanjit Aulakh
Examiner (ID: 11601)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1612, 1203, 1621 |
| Total Applications | 3765 |
| Issued Applications | 2855 |
| Pending Applications | 383 |
| Abandoned Applications | 582 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8266099
[patent_doc_number] => 20120165530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'NAPHTHALENE MONOIMIDE DERIVATIVES AND USE THEREOF AS PHOTOSENSITIZERS IN SOLAR CELLS AND PHOTODETECTORS'
[patent_app_type] => utility
[patent_app_number] => 13/331647
[patent_app_country] => US
[patent_app_date] => 2011-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6276
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13331647
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/331647 | Naphthalene monoimide derivatives and use thereof as photosensitizers in solar cells and photodetectors | Dec 19, 2011 | Issued |
Array
(
[id] => 8128541
[patent_doc_number] => 20120088821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-12
[patent_title] => 'METHOD FOR TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/327548
[patent_app_country] => US
[patent_app_date] => 2011-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6014
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0088/20120088821.pdf
[firstpage_image] =>[orig_patent_app_number] => 13327548
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/327548 | METHOD FOR TREATING ATHEROSCLEROSIS OR RESTENOSIS USING MICROTUBULE STABILIZING AGENT | Dec 14, 2011 | Abandoned |
Array
(
[id] => 10063090
[patent_doc_number] => 09101920
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-11
[patent_title] => 'Palladium catalyst, method for its preparation and its use'
[patent_app_type] => utility
[patent_app_number] => 13/994651
[patent_app_country] => US
[patent_app_date] => 2011-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7991
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13994651
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/994651 | Palladium catalyst, method for its preparation and its use | Dec 12, 2011 | Issued |
Array
(
[id] => 9206220
[patent_doc_number] => 20140005397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'METAL COMPLEX COMPRISING A LIGAND HAVING A COMBINATION OF DONOR-ACCEPTOR SUBSTITUENTS'
[patent_app_type] => utility
[patent_app_number] => 13/988267
[patent_app_country] => US
[patent_app_date] => 2011-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7644
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988267
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/988267 | Metal complex comprising a ligand having a combination of donor-acceptor substituents | Nov 20, 2011 | Issued |
Array
(
[id] => 8430971
[patent_doc_number] => 20120252847
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'NOVEL FORM OF S-OMEPRAZOLE'
[patent_app_type] => utility
[patent_app_number] => 13/298373
[patent_app_country] => US
[patent_app_date] => 2011-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4502
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13298373
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/298373 | Form of S-omeprazole | Nov 16, 2011 | Issued |
Array
(
[id] => 9524340
[patent_doc_number] => 08748611
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => 'Processes for preparing morphinan-6-one products with low levels of alpha beta-unsaturated compounds'
[patent_app_type] => utility
[patent_app_number] => 13/294546
[patent_app_country] => US
[patent_app_date] => 2011-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12382
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13294546
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/294546 | Processes for preparing morphinan-6-one products with low levels of alpha beta-unsaturated compounds | Nov 10, 2011 | Issued |
Array
(
[id] => 10974748
[patent_doc_number] => 20140377783
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-12-25
[patent_title] => 'NOVEL APPLICATIONS OF INDOLOINDOLE AND INDOLOQUINOLINE DYES'
[patent_app_type] => utility
[patent_app_number] => 13/883067
[patent_app_country] => US
[patent_app_date] => 2011-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7328
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883067
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/883067 | Applications of Indoloindole and Indoloquinoline dyes | Nov 3, 2011 | Issued |
Array
(
[id] => 8187202
[patent_doc_number] => 20120116085
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-10
[patent_title] => 'METHOD FOR THE MANUFACTURING OF NALTREXONE'
[patent_app_type] => utility
[patent_app_number] => 13/287391
[patent_app_country] => US
[patent_app_date] => 2011-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4634
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20120116085.pdf
[firstpage_image] =>[orig_patent_app_number] => 13287391
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/287391 | Method for the manufacturing of naltrexone | Nov 1, 2011 | Issued |
Array
(
[id] => 10169322
[patent_doc_number] => 09200023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-01
[patent_title] => 'Method for producing complex of trisortho-metalated iridium, light-emitting material using said complex, and light-emitting element'
[patent_app_type] => utility
[patent_app_number] => 13/876937
[patent_app_country] => US
[patent_app_date] => 2011-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11637
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876937
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/876937 | Method for producing complex of trisortho-metalated iridium, light-emitting material using said complex, and light-emitting element | Oct 24, 2011 | Issued |
Array
(
[id] => 10548422
[patent_doc_number] => 09273032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Photolabile compounds'
[patent_app_type] => utility
[patent_app_number] => 13/279876
[patent_app_country] => US
[patent_app_date] => 2011-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 14390
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13279876
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/279876 | Photolabile compounds | Oct 23, 2011 | Issued |
Array
(
[id] => 7778963
[patent_doc_number] => 20120041204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'PROCESS FOR PRODUCING TRICYCLIC KETONE'
[patent_app_type] => utility
[patent_app_number] => 13/278579
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12972
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20120041204.pdf
[firstpage_image] =>[orig_patent_app_number] => 13278579
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/278579 | Process for producing tricyclic ketone | Oct 20, 2011 | Issued |
Array
(
[id] => 8265931
[patent_doc_number] => 20120165356
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 13/274616
[patent_app_country] => US
[patent_app_date] => 2011-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 134173
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13274616
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/274616 | SPIROCYCLIC HETEROCYCLIC DERIVATIVES AND METHODS OF THEIR USE | Oct 16, 2011 | Abandoned |
Array
(
[id] => 8784722
[patent_doc_number] => 08431566
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-30
[patent_title] => 'Cyclopamine lactam analogs and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/250080
[patent_app_country] => US
[patent_app_date] => 2011-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17184
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13250080
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/250080 | Cyclopamine lactam analogs and methods of use thereof | Sep 29, 2011 | Issued |
Array
(
[id] => 9964857
[patent_doc_number] => 09012469
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-21
[patent_title] => 'Crystalline naloxol-peg conjugate'
[patent_app_type] => utility
[patent_app_number] => 13/823953
[patent_app_country] => US
[patent_app_date] => 2011-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13385
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13823953
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/823953 | Crystalline naloxol-peg conjugate | Sep 28, 2011 | Issued |
Array
(
[id] => 7738708
[patent_doc_number] => 20120018713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Nitrogen-containing heteroaromatic ligand-transition metal complexes, buffer layer comprising the complexes and organic thin film transistor comprising the buffer layer'
[patent_app_type] => utility
[patent_app_number] => 13/200321
[patent_app_country] => US
[patent_app_date] => 2011-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6732
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20120018713.pdf
[firstpage_image] =>[orig_patent_app_number] => 13200321
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/200321 | Nitrogen-containing heteroaromatic ligand-transition metal complexes, buffer layer comprising the complexes and organic thin film transistor comprising the buffer layer | Sep 22, 2011 | Issued |
Array
(
[id] => 7744535
[patent_doc_number] => 20120022097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Compositions and Methods for Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/236969
[patent_app_country] => US
[patent_app_date] => 2011-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5028
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022097.pdf
[firstpage_image] =>[orig_patent_app_number] => 13236969
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/236969 | Compositions and methods for treating cancer | Sep 19, 2011 | Issued |
Array
(
[id] => 9331150
[patent_doc_number] => 20140057931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'BUPRENORPHINE ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 13/825241
[patent_app_country] => US
[patent_app_date] => 2011-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 180927
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 31
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825241
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/825241 | Buprenorphine analogs | Sep 19, 2011 | Issued |
Array
(
[id] => 8359616
[patent_doc_number] => 20120214765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-23
[patent_title] => 'BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/236543
[patent_app_country] => US
[patent_app_date] => 2011-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 141
[patent_figures_cnt] => 141
[patent_no_of_words] => 140328
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13236543
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/236543 | Boron-containing small molecules as anti-inflammatory agents | Sep 18, 2011 | Issued |
Array
(
[id] => 7716919
[patent_doc_number] => 20120007058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'Organic memory device using iridium organometallic compound and fabrication method thereof'
[patent_app_type] => utility
[patent_app_number] => 13/137839
[patent_app_country] => US
[patent_app_date] => 2011-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6612
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20120007058.pdf
[firstpage_image] =>[orig_patent_app_number] => 13137839
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/137839 | Organic memory device using iridium organometallic compound and fabrication method thereof | Sep 15, 2011 | Abandoned |
Array
(
[id] => 9575538
[patent_doc_number] => 08765952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-01
[patent_title] => 'Metal complex, light emitting element, and display device'
[patent_app_type] => utility
[patent_app_number] => 13/825269
[patent_app_country] => US
[patent_app_date] => 2011-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 26
[patent_no_of_words] => 17945
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825269
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/825269 | Metal complex, light emitting element, and display device | Sep 14, 2011 | Issued |